Stay updated on Durvalumab Combo in Chinese Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The history now includes a new site revision (v3.7.0) replacing the previous revision (v3.6.6). This indicates a UI/system update rather than changes to the study record data.
    Difference
    0.1%
    Check dated 2026-09-21T22:36:50.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 has been added to the Record History. This updates the page's version log and supersedes the previous v3.6.5 entry.
    Difference
    0.1%
    Check dated 2026-08-31T17:22:46.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.5, was added to the study's record history, replacing Revision: v3.6.4. This indicates a software/interface update to the ClinicalTrials.gov page.
    Difference
    0.1%
    Check dated 2026-08-17T12:44:57.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    New revision label v3.6.4 was added to the study record history, replacing the previous v3.6.3. This indicates a minor update to the page history rather than a change to the study data or content.
    Difference
    0.1%
    Check dated 2026-07-27T06:18:35.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was added to the study record history, replacing the previous v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-05T13:22:04.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The study record title was updated to use the uHCC abbreviation and corrected wording, and the recruitment status was changed to Active, not recruiting; additional sections such as Contacts/Locations, Eligibility, Outcome Measures, and Arms and Interventions were added.
    Difference
    2%
    Check dated 2026-06-28T08:36:37.000Z thumbnail image

Stay in the know with updates to Durvalumab Combo in Chinese Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Chinese Liver Cancer Clinical Trial page.